Eugene B. Buynak
- Epidemiology top 1%
- Infectious Diseases top 2%
- Health top 1%
- Immunology top 5%
- Hepatology top 2%
- Co-authors
- M. R. HillemanRobert E. WeibelJoseph StokesW. J. McAleerA. A. McLeanD. Eugene WamplerRobert Z. MaigetterWilliam J. Miller
- Topics
- Virology and Viral Diseases (44 papers)SARS-CoV-2 and COVID-19 Research (22 papers)Vaccine Coverage and Hesitancy (19 papers)
- Cited by
- HealthEpidemiologyVirology
- Partner nations
- United States
In The Last Decade
Eugene B. Buynak
60 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Epidemiology 2.0k
- Infectious Diseases 773
- Health 571
- Immunology 530
- Hepatology 344
Countries citing papers authored by Eugene B. Buynak
This map shows the geographic impact of Eugene B. Buynak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene B. Buynak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene B. Buynak more than expected).
Fields of papers citing papers by Eugene B. Buynak
This network shows the impact of papers produced by Eugene B. Buynak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene B. Buynak. The network helps show where Eugene B. Buynak may publish in the future.
Co-authorship network of co-authors of Eugene B. Buynak
This figure shows the co-authorship network connecting the top 25 collaborators of Eugene B. Buynak. A scholar is included among the top collaborators of Eugene B. Buynak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene B. Buynak. Eugene B. Buynak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 309 | |
| 3 | Human hepatitis B vaccine from recombinant yeastbreakdown → | 529 |
| 4 | Quality and safety of human hepatitis B vaccine. | 12 |
| 5 | 16 | |
| 6 | 10 | |
| 7 | 43 | |
| 8 | 18 | |
| 9 | 53 | |
| 10 | 4 | |
| 11 | 74 | |
| 12 | 10 | |
| 13 | 7 | |
| 14 | Jeryl Lynn strain live mumps virus vaccine. | 1 |
| 15 | 1 | |
| 16 | 5 | |
| 17 | 19 | |
| 18 | 80 | |
| 19 | 13 | |
| 20 | 1 |
About Eugene B. Buynak
Eugene B. Buynak is a scholar working on Health, Epidemiology and Infectious Diseases, having authored 62 papers that have together received 2.5k indexed citations. Recurring topics across this work include Virology and Viral Diseases (44 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Vaccine Coverage and Hesitancy (19 papers). The work is most often cited by research in Health (571 citations), Epidemiology (2.0k citations) and Virology (246 citations). Eugene B. Buynak has collaborated with scholars based in United States. Frequent co-authors include M. R. Hilleman, Robert E. Weibel, Joseph Stokes, W. J. McAleer, A. A. McLean, M. R. Hilleman, D. Eugene Wampler, Robert Z. Maigetter, William J. Miller and B. J. Neff. Their work appears in journals such as Nature, New England Journal of Medicine and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.